Market revenue in 2023 | USD 10.8 million |
Market revenue in 2030 | USD 13.4 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Primary |
Fastest growing segment | Primary |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Primary, Secondary |
Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research antibodies market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 75.93% in 2023. Horizon Databook has segmented the South Africa research antibodies market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
The South Africa research antibodies market growth is expected to be influenced by National Health Insurance program and the Competition Commission. The National Health Insurance system of South Africa is designed with an aim to pool funds to deliver access of good quality personal health services at affordable costs for all South Africans.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa research antibodies market , including forecasts for subscribers. This country databook contains high-level insights into South Africa research antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account